menu
search

Search to find the correct information:
search
Search

Biotech

Showing of Insights Posts
Health care Biotech Innovation Economic cycle Equity Global Industry Research Article Outlook
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Health care outlook for 2023

Looking ahead to 2023, members of our health care team see meaningful innovation, supportive valuations, and a benign political and regulatory backdrop across biopharma, medical tech, and health care services sectors.

Continue reading

Multiple authors

event
Article
2023-12-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
Equity Biotech Macro and market Fiscal policy USA Quick Take
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
Drug pricing reform: A bitter pill for biopharma?
Global Industry Analyst Wen Shi considers the implications of drug price reform for biotech companies — modest in the near term, but likely negative longer term.
Continue reading

By

Wen Shi, PhD, CFA

event
Quick Take
2023-01-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
2 LOAD {count} MORE

URL References

Related Insights